Genomed Health Care Center (NZOZ Genomed), established in 2008, has the richest genetic testing offer in Poland. We invite you to acquaint yourself with our ever-expanding molecular diagnostics offer, which includes the analysis of whole exome (WES) and whole genome (WGS) sequences.

Genomed is the only company whose staff and technological base allow offering all types of services involving Next Generation Sequencing (NGS).

Currently, we offer Whole Genome Sequencing (WGS)  with a diagnostic analysis of over 5,000 genes responsible for genetic disorders at 3 100 EUR.

Check your future


Genomed was created with the aim of developing molecular diagnostics based on DNA sequencing and to introduce methods which use Next Generation Sequencing (NGS) to the Polish and European markets.


Genomed meets the demand for services connected with molecular diagnostics based on DNA sequencing in the most effective and innovative way. The company’s offer currently includes the analysis of mutations responsible for congenital diseases occurring in any of the known 6,500 genes related to genetic diseases using the NGS technology.

The Genomed team can analyze gene sequences in search of practically any of the mutations connected with congenital diseases. Only the best of the world’s genetic diagnostics establishments can boast such a wide-ranging offer. Customer trust and technological advantage over the competition guarantee a constant increase in the revenue from the company’s activities and a maximization of the return on invested capital. 

The company’s current activities are directed toward introducing genomic technology to personalized medicine, a new sector of services connected with protecting our health. Genomed is a leading personalized medicine establishment, whose main objectives are introducing genomic prevention to medical practice and creating a clinic offering gene treatments. We also provide diverse DNA sequencing, analysis and synthesis services for research and the biotechnological market.